Author: user
-
Pyx Health to Accelerate Growth with Strategic Investment from TT Capital Partners
—
MINNEAPOLIS–(BUSINESS WIRE)–Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation, today announced a majority growth investment from TT Capital Partners (TTCP). The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces…
-
PBS, Arizona Horizon – Implantable Brain Tumor Treatment
—
Tempe, Arizona – GT Medical Technologies has created a new way to target brain tumors like the type that took the late Senator John McCain’s life. GammaTile technology, invented and developed in Arizona, consists of four tiles implanted in a patient. These tiles contain dosages of radiation that targets glioblastomas. We’ll get more from Dr. David…
-
BLUESTONE DIRECTOR, ANDREW MORE, RECOGNIZED AS A 2019 EMERGING LEADER BY THE M&A ADVISOR
—
Tucson, AZ, May 31, 2019 – Recently, The M&A Advisor announced the winners of the 2019 Emerging Leaders Awards. The M&A Advisor, renowned globally for its recognition of leading M&A, financing and turnaround professionals, created this event to promote mentorship and professional development amongst the emerging business leaders. Andrew More has been chosen for his…
-
Paradigm Diagnostics Announces the Addition of Industry Executive Mara Aspinall to the Board of Directors as Part of the Series B Extension Closing Totaling $15 Million
Phoenix, Arizona – Paradigm Diagnostics, a leading precision medicine company focused on comprehensive cancer testing, announced the addition of Mara Aspinall, Managing Director of BlueStone Venture Partners, to the Board of Directors as part of the closing of Paradigm’s $15 million Series B fundraising. In addition to participation by the founding investors, Mesa Verde Venture Partners, New…
-
The Creative City Show – Venture Capital and the Innovation Ecosystem in Tucson
—
Tucson, Arizona – Mara and Andrew join The Creative City Show host Zach Yentzer for a conversation on venture capital, the innovation ecosystem in Tucson, and the 4th industrial revolution. LISTEN HERE
-
UCSF Rosenman Institute – Preventing Brain Cancer Recurrence with GammaTiles
—
Tempe, Arizona –Listen to The Health Technology podcast from UCSF Rosenman Institute to hear GT Medical Technologies, Inc. CEO Matt Likens share how GammaTile Therapy challenges the current standard of care for patients with recurrent brain tumors by improving quality of life and delaying time to recurrence for all tumor pathologies (gliomas, meningiomas, metastases, etc.). LISTEN HERE
-
GT Medical Technologies Co-Founder to Receive Prestigious Rosenblum-Mahaley Clinical Research Award at 2019 American Association of Neurological Surgeons Annual Scientific Meeting
—
Tempe, Arizona & San Diego, California – BlueStone portfolio company GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that Peter Nakaji, M.D., GT MedTech’s co-founder and director of the Neurosurgery Residency Program at Barrow Neurological Institute in Phoenix, has been selected by the American Association of Neurological…
-
University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors
—
Tempe, Arizona & Minneapolis, Minnesota – University of Minnesota Health (M Health) is the first health system in the United States to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT™) that is designed to delay tumor regrowth for patients with brain tumors.…
-
Doctors at the University of Minnesota are the first in the country to use a breakthrough brain cancer treatment
—
Minneapolis, Minnesota – It sounds like science fiction, but doctors at University of Minnesota Health are the first in the country to offer an implantable form of radiation to target brain cancer. The implant is called GammaTile Therapy and Linda Tinega was the first patient in Minnesota to receive it. “Each tile, has four, radioactive seeds on…
-
GT Medical Technologies Announces $10 Million Financing to Support Launch of Targeted Therapy for Patients with Recurrent Brain Tumors
Tempe, Arizona – GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that it has raised $10 million in a Series A financing led by MedTech Venture Partners with participation from BlueStone Venture Partners. Funds from the round will support the commercialization of GammaTile™ Therapy, an FDA-cleared,…
-
BlueStone Venture Partners, A Local Venture Capital Fund
—
Tucson, Arizona – The mantra, “Why not us?” has been used across a wide spectrum of issues ranging from economic development to politics to sports. In Southern Arizona and the Southwest region, it is applying to venture capital, an industry that has been notably centered in two hubs – the Bay Area in California, including the…
-
BroadSpot Imaging Corporation Expands Series A Investment
Richmond, California – BroadSpot Imaging Corporation, a medical device company focused on transforming patient access to superior eye-based diagnostics for ophthalmic and other medical conditions, has expanded the second tranche of its Series A funding for a total closing of $8.6M. BroadSpot will use the funds to manufacture and launch its first suite of low cost, ultra-widefield…
-
USNews & World Report: State Funding to Spur Development of Bioscience Startups
—
Santa Fe, New Mexico – A state economic development fund is providing up to $3 million to help spur growth of New Mexico bioscience startups. Gov. Susana Martinez announced Thursday the Catalyst Fund will provide the funding to BlueStone Venture Partners LLC which in turn will match the state funding and invest in technology companies in early stages…
-
Governor Susana Martinez Announces New Catalyst Fund Commitment to BlueStone Venture Partners
—
Santa Fe, New Mexico – A new venture fund is scouting for local health science startups to invest in, backed by $3 million from the state Catalyst Fund. BlueStone Venture Partners LLC, with offices in Tucson and Santa Fe, must match the state commitment with $3 million from private investors, making at least $6 million available for…
-
BlueStone Venture Partners Announces Initial Funding Close and State of New Mexico Investment in Its Inaugural Venture Fund
—
Tucson, Arizona & Santa Fe, New Mexico – BlueStone Venture Partners, with offices in Tucson, Arizona and Santa Fe, New Mexico, announced its First Close for the BlueStone Life Sciences Innovation & Technology Fund, LP. BlueStone is focused on Series A and B equity investments in opportunities in the advanced materials, biopharma, healthcare information technology, medical devices,…